Economic burden of cardiovascular diseases in the European Union: a population-based cost study
LEAL J. et al, (2023), European Heart Journal
Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries
LEAL J., (2023), European Heart Journal - Quality of Care and Clinical Outcomes
Estimating the Economic Value of Automated Virtual Reality Cognitive Therapy for Treating Agoraphobic Avoidance in Patients With Psychosis: Findings From the gameChange Randomized Controlled Clinical Trial
Altunkaya J. et al, (2022), Journal of Medical Internet Research
Rehabilitation versus surgical reconstruction for non-acute anterior cruciate ligament injury (ACL SNNAP): a pragmatic randomised controlled trial.
Beard DJ. et al, (2022), Lancet, 400, 605 - 615
The WISDOM self-management intervention: a cost-effectiveness analysis to support the transformation of type 2 diabetes care in England.
Singh S. et al, (2022), Diabet Med
Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double-blind, placebo-controlled trial.
Leal J. et al, (2022), Journal of diabetes, 14, 455 - 464
Hospital costs associated with adverse events in people with diabetes in the UK
Keng MJ. et al, (2022), Diabetes, Obesity and Metabolism
The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model.
Emamipour S. et al, (2022), Acta Diabetol
ACL Surgery Necessity in Non-Acute Patients (ACL SNNAP): A statistical analysis plan for a randomised controlled trial
STOKES J. et al, (2022), Trials
Cost-effectiveness of home-based stroke rehabilitation across Europe: A modelling study.
Candio P. et al, (2022), Health Policy
Impact of adverse events on hospital costs and health-related quality of life in people with diabetes
Keng MJ. et al, (2022), DIABETES RESEARCH AND CLINICAL PRACTICE, 186